Position in NVO
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$15,268,122
+$3,333,891 QoQ
Shares Held
318,484
-1.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#120
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. NVO ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,268,122 | 318,484 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $11,934,231 | 324,741 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $16,233,823 | 319,061 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $17,266,712 | 311,168 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,891,809 | 273,715 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $13,170,823 | 189,672 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $16,386,810 | 190,500 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $23,071,360 | 193,763 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,851,143 | 195,118 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $25,599,108 | 199,370 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $21,753,052 | 210,276 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $19,285,372 | 212,067 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,295,581 | 106,875 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $17,261,915 | 108,470 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $14,961,972 | 110,551 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $11,177,091 | 112,186 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $12,703,131 | 114,001 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $12,685,352 | 114,231 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $12,843,488 | 114,674 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,131,783 | 115,944 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,642,680 | 115,109 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,863,801 | 116,639 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $8,261,508 | 118,275 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,403,737 | 121,039 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $8,168,433 | 124,747 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,665,266 | 127,330 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||